V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210035971 | 210009428 | 1.6 | null | Curative (C) | 2014-01-30 | 2014-01-30 | VINCRISTINE | N | N | 210018697 | VINCRISTINE |
| 210035972 | 210009436 | 1.74 | 122 | Disease modification (D) | 2017-05-03 | 2017-07-02 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 210018723 | FCR |
| 210035974 | 210026891 | null | 69 | Unknown (U) | 2016-02-15 | 2016-09-10 | FCR | N | null | 210019278 | FCR |
| 210035975 | 210009680 | 1.73 | 77.9 | Curative (C) | 2016-11-26 | 2017-01-06 | CHLORAMBUCIL + OBINUTUZUMAB | Y | N | 210019528 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210035976 | 210009705 | null | 56 | Curative (C) | 2015-08-01 | 2015-11-29 | IDELALISIB + RITUXIMAB | N | N | 210019611 | IDELALISIB + RITUXIMAB |
| 210035977 | 210009726 | 1.65 | 80 | Disease modification (D) | 2016-08-20 | 2016-08-30 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210019671 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210035978 | 210009734 | 1.62 | 65.5 | Curative (C) | 2017-03-06 | 2017-07-22 | ALL UKALL60+ TRIAL | Y | N | 210019691 | UKALL60+ |
| 210035979 | 210009825 | 1.58 | 77 | Curative (C) | null | 2018-09-20 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210019979 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210035980 | 210009917 | null | null | Curative (C) | 2018-06-21 | 2018-08-07 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210020337 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210035981 | 210009968 | null | 29.3 | Palliative (P) | 2015-06-28 | 2015-11-08 | Triple Intrathecal | Y | null | 210020530 | TRIPLE INTRATHECAL |
| 210035982 | 210010015 | null | null | Disease modification (D) | 2015-06-20 | 2017-02-11 | CHLORAMBUCIL + RITUXIMAB | Y | N | 210020678 | CHLORAMBUCIL + RITUXIMAB |
| 210035983 | 210010041 | 0 | 71.2 | Curative (C) | 2018-10-11 | 2019-09-19 | METHOTREXATE | N | N | 210020804 | METHOTREXATE |
| 210035984 | 210027046 | 0 | 106 | Curative (C) | 2016-02-15 | 2016-12-14 | Imatinib 400mg | N | N | 210020935 | IMATINIB |
| 210035985 | 210010086 | 1.73 | 0 | Adjuvant (A) | 2014-07-03 | 2015-03-04 | ALL UKALL2003 TRIAL | N | N | 210020956 | UKALL 2003 |
| 210035986 | 210010097 | 1.73 | 83.3 | Curative (C) | 2013-11-21 | 2013-12-23 | R Chlorambucil | N | N | 210020995 | CHLORAMBUCIL + RITUXIMAB |
| 210035987 | 210010130 | 0 | 83 | Disease modification (D) | 2016-08-28 | 2016-09-02 | IMATINIB | 02 | N | 210021134 | IMATINIB |
| 210035988 | 210020511 | 1.69 | 69.3 | Curative (C) | 2015-11-10 | 2016-03-30 | Methotrexate 10mg/m2 po 7day | Y | N | 210021185 | METHOTREXATE |
| 210035990 | 210020532 | 1.61 | 50 | Curative (C) | null | 2018-12-13 | IDELALISIB + RITUXIMAB | 1 | N | 210021253 | IDELALISIB + RITUXIMAB |
| 210035991 | 210010179 | null | null | Disease modification (D) | 2019-12-06 | 2020-01-09 | CHLORAMBUCIL + OBINUTUZUMAB | 99 | null | 210021285 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210035992 | 210010191 | 1.5 | 80 | Disease modification (D) | 2018-11-08 | 2018-11-15 | Triple / Double Intrathecal Therapy | 02 | N | 210021334 | TRIPLE INTRATHECAL |
| 210035993 | 210020555 | 1.73 | 106 | Curative (C) | 2016-12-21 | 2017-02-08 | ALL UKALL60+ TRIAL | N | N | 210021343 | UKALL60+ |
| 210035994 | 210010206 | 1.66 | 76.5 | Palliative (P) | 2018-01-01 | 2018-03-29 | ALL UKALL60+ TRIAL | N | N | 210021363 | UKALL60+ |
| 210035995 | 210020571 | 1.77 | 76 | Curative (C) | 2016-08-22 | 2016-10-02 | Triple / Double Intrathecal Therapy | 1 | N | 210021410 | TRIPLE INTRATHECAL |
| 210035996 | 210010233 | 0 | 72.1 | Disease modification (D) | 2016-07-22 | 2016-07-22 | CHLORAMBUCIL + RITUXIMAB | N | N | 210021499 | CHLORAMBUCIL + RITUXIMAB |
| 210035997 | 210010239 | 1.6 | 62.1 | Curative (C) | null | 2019-03-25 | ALL UKALL2003 TRIAL | null | null | 210021523 | UKALL 2003 |
| 210035998 | 210010255 | null | 82.7 | Disease modification (D) | 2015-03-04 | 2015-06-05 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210021606 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210035999 | 210010276 | 1.86 | 76.5 | Curative (C) | 2013-05-31 | 2014-04-04 | Triple Intrathecal | N | N | 210021729 | TRIPLE INTRATHECAL |
| 210036000 | 210010297 | 1.66 | null | null | 2018-01-08 | 2018-04-16 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210021799 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210036001 | 210010303 | 1.64 | 52.8 | Curative (C) | null | 2016-05-01 | ALL UKALL2003 TRIAL | 2 | N | 210021830 | UKALL 2003 |
| 210036002 | 210010332 | 1.64 | 97.5 | Curative (C) | 2019-04-30 | 2019-04-30 | R Chlorambucil | N | N | 210021949 | CHLORAMBUCIL + RITUXIMAB |
| 210036003 | 210010463 | null | 64.9 | Curative (C) | 2018-05-21 | 2018-05-22 | IMATINIB | N | N | 210023222 | IMATINIB |
| 210036004 | 210010469 | null | 46.2 | Curative (C) | 2015-12-26 | 2016-05-02 | ALL UKALL2003 TRIAL | Y | N | 210023251 | UKALL 2003 |
| 210036005 | 210010494 | 1.64 | 70 | Palliative (P) | 2018-02-04 | 2018-02-05 | ALL UKALL60+ TRIAL | N | N | 210023423 | UKALL60+ |
| 210036008 | 210010697 | 1.77 | 53.7 | Curative (C) | 2016-06-07 | 2016-08-24 | CHLORAMBUCIL + RITUXIMAB | 2 | N | 210025775 | CHLORAMBUCIL + RITUXIMAB |
| 210036009 | 210010759 | 1.79 | 110.7 | Curative (C) | 2017-09-14 | 2017-09-14 | IDELALISIB + RITUXIMAB | 2 | N | 210026643 | IDELALISIB + RITUXIMAB |
| 210036010 | 210010778 | 1.66 | 82 | Curative (C) | 2017-11-12 | 2018-03-18 | IMATINIB | Y | N | 210026869 | IMATINIB |
| 210036011 | 210033382 | 1.74 | 86 | Curative (C) | 2016-11-08 | 2017-01-01 | IDELALISIB + RITUXIMAB | N | N | 210026957 | IDELALISIB + RITUXIMAB |
| 210036012 | 210010797 | 1.63 | 39.6 | Palliative (P) | 2017-07-08 | 2017-10-15 | METHOTREXATE | N | N | 210027027 | METHOTREXATE |
| 210036013 | 210010803 | 1.61 | 74.4 | Curative (C) | 2016-02-05 | 2016-05-14 | ALL UKALL2003 TRIAL | 2 | N | 210027036 | UKALL 2003 |
| 210036014 | 210010811 | 1.6 | 72.5 | Adjuvant (A) | 2016-02-07 | 2016-02-09 | IDELALISIB + RITUXIMAB | N | N | 210027083 | IDELALISIB + RITUXIMAB |
| 210036015 | 210010813 | 0 | 87.2 | Curative (C) | 2017-04-22 | 2017-09-29 | METHOTREXATE | 02 | N | 210027099 | METHOTREXATE |
| 210036016 | 210010819 | 1.6 | 94.5 | Palliative (P) | 2017-05-04 | 2017-08-05 | IDELALISIB + RITUXIMAB | 2 | N | 210027124 | IDELALISIB + RITUXIMAB |
| 210036017 | 210010853 | 1.85 | 61.8 | Adjuvant (A) | 2013-04-02 | 2015-05-04 | ALL UKALL2003 TRIAL | 01 | N | 210027335 | UKALL 2003 |
| 210036018 | 210010866 | 1.79 | 73.5 | Curative (C) | 2019-09-22 | 2019-09-23 | IDELALISIB + RITUXIMAB | N | N | 210027506 | IDELALISIB + RITUXIMAB |
| 210036019 | 210010875 | null | 52.3 | Adjuvant (A) | 2016-11-28 | 2017-04-30 | IMATINIB | N | N | 210027529 | IMATINIB |
| 210036020 | 210010890 | 1.7 | 84 | Palliative (P) | null | 2018-07-04 | IMATINIB | N | N | 210027613 | IMATINIB |
| 210036021 | 210010906 | null | null | null | 2016-02-18 | 2016-02-18 | Triple / Double Intrathecal Therapy | Y | N | 210027736 | TRIPLE INTRATHECAL |
| 210036022 | 210021090 | null | 94 | Curative (C) | 2017-09-25 | 2018-04-10 | Venetoclax | 01 | N | 210027745 | VENETOCLAX |
| 210036023 | 210010923 | null | 95.6 | Curative (C) | 2014-07-23 | 2015-04-29 | Mercaptopurine | N | N | 210027813 | MERCAPTOPURINE |
| 210036024 | 210010933 | 1.72 | 73.5 | Curative (C) | 2014-10-22 | 2014-11-19 | FLAG + Idarubicin | N | null | 210027853 | FLAG + IDARUBICIN |